These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 9230743

  • 101. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
    Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ.
    Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684
    [Abstract] [Full Text] [Related]

  • 102. Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
    San Miguel-Pagola M, Reychler G, Cebrià I Iranzo MA, Gómez-Romero M, Díaz-Gutiérrez F, Herrero-Cortina B.
    Physiotherapy; 2020 Jun; 107():243-251. PubMed ID: 32026826
    [Abstract] [Full Text] [Related]

  • 103.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 104.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 105.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 106.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 107.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 108.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 109. Where we are now with rhDNase.
    Geddes DM, Shah PL.
    Lancet; 1999 May 22; 353(9166):1727. PubMed ID: 10347981
    [No Abstract] [Full Text] [Related]

  • 110.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 111. [Pharmacological and clinical profiles of Dornase alfa (Pulmozyme®) in the management of cystic fibrosis patients to improve pulmonary function].
    Kokubo H, Hosatani S, Ichikawa M.
    Nihon Yakurigaku Zasshi; 2013 Apr 22; 141(4):213-9. PubMed ID: 23575427
    [No Abstract] [Full Text] [Related]

  • 112.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 113.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 114. rhDNase in cystic fibrosis.
    Tyrrell JC, Lewis PA, Sheldon CD, Connett G.
    Thorax; 1999 Aug 22; 54(8):752. PubMed ID: 10490419
    [No Abstract] [Full Text] [Related]

  • 115. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
    Daviskas E, Robinson M, Anderson SD, Bye PT.
    J Aerosol Med; 2002 Aug 22; 15(3):331-41. PubMed ID: 12396422
    [Abstract] [Full Text] [Related]

  • 116. [Clinical development of rhDNase in the United States].
    Eisenberg J.
    Arch Pediatr; 1995 Jul 22; 2(7):674-8. PubMed ID: 7663659
    [Abstract] [Full Text] [Related]

  • 117.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 118.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 119.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 120. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.
    Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y.
    Pharm Res; 2010 Jan 22; 27(1):151-60. PubMed ID: 19847626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.